Clearmind Medicine Inc.

US$5.58As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:CMNDHealthcare
Country USA
PE (Fwd) •••
TSR 5Y CAGR (86.76%)
Div yield —
ROE (106.98%)
Biotechnology
Beta (5Y) 0.51
PE TTM —
TSR TTM (97.81%)
Mkt cap US$2.350M
ROIC (69.96%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$5.64
0.92%
14.18%
Hold 7|10|11|3|0
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.06
0.05
0.06
0.06
7.32%
3.19%
17.61%
14.95%
Revenue$M
0.227
0.229
0.231
0.232
4.19%
3.51%
4.17%
5.39%
Peers (US$2.350M)
Cap (US$)
PE
2.993M
0.870x
2.312M
—
2.349M
—
Capital
TTM
5Y
10Y
Leveragex
2.032
0.378
0.373
EBIT/Intx
0.698
0.312
0.289
Own earn%
(71.64)
67.83
47.21
Sh yield%
26.68
21.04
19.17
Owners
Insiders/Inst%
4.91
80.89
Short interest%
0.77
SBC / revenue%
4.91
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
15
Op margin range%
27–31
$1 testx
—
Incr. ROIC%
5